213 related articles for article (PubMed ID: 32435886)
1. Prognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breast.
Westhoff CC; Jank P; Jacke CO; Albert US; Ebrahimsade S; Barth PJ; Moll R
Virchows Arch; 2020 Nov; 477(5):717-724. PubMed ID: 32435886
[TBL] [Abstract][Full Text] [Related]
2. Myofibroblastic reaction is a common event in metastatic disease of breast carcinoma: a descriptive study.
Catteau X; Simon P; Noël JC
Diagn Pathol; 2014 Oct; 9():196. PubMed ID: 25339428
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast.
Yazhou C; Wenlv S; Weidong Z; Licun W
Tumour Biol; 2004; 25(5-6):290-5. PubMed ID: 15627894
[TBL] [Abstract][Full Text] [Related]
4. CD34+ fibrocytes are preserved in most invasive lobular carcinomas of the breast.
Ebrahimsade S; Westhoff CC; Barth PJ
Pathol Res Pract; 2007; 203(9):695-8. PubMed ID: 17656039
[TBL] [Abstract][Full Text] [Related]
5. CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx.
Barth PJ; Schenck zu Schweinsberg T; Ramaswamy A; Moll R
Virchows Arch; 2004 Mar; 444(3):231-4. PubMed ID: 14758552
[TBL] [Abstract][Full Text] [Related]
6. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
[TBL] [Abstract][Full Text] [Related]
7. Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast.
Catteau X; Simon P; Vanhaeverbeek M; Noël JC
PLoS One; 2013; 8(3):e57773. PubMed ID: 23469238
[TBL] [Abstract][Full Text] [Related]
8. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.
Park CK; Jung WH; Koo JS
Breast Cancer Res Treat; 2016 Aug; 159(1):55-69. PubMed ID: 27469595
[TBL] [Abstract][Full Text] [Related]
9. Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway.
Catteau X; Simon P; Noël JC
BMC Cancer; 2014 Jul; 14():499. PubMed ID: 25011545
[TBL] [Abstract][Full Text] [Related]
10. Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome.
Yamashita M; Ogawa T; Zhang X; Hanamura N; Kashikura Y; Takamura M; Yoneda M; Shiraishi T
Breast Cancer; 2012 Apr; 19(2):170-6. PubMed ID: 20978953
[TBL] [Abstract][Full Text] [Related]
11. CD34+ fibrocytes in tubular carcinomas and radial scars of the breast.
Ramaswamy A; Moll R; Barth PJ
Virchows Arch; 2003 Oct; 443(4):536-40. PubMed ID: 12898244
[TBL] [Abstract][Full Text] [Related]
12. CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder.
Nimphius W; Moll R; Olbert P; Ramaswamy A; Barth PJ
Virchows Arch; 2007 Feb; 450(2):179-85. PubMed ID: 17149610
[TBL] [Abstract][Full Text] [Related]
13. Invasive micropapillary carcinoma of the breast: an immunohistochemical study of neoplastic and stromal cells.
Kuroda N; Sugimoto T; Takahashi T; Moriki T; Toi M; Miyazaki E; Hiroi M; Enzan H
Int J Surg Pathol; 2005 Jan; 13(1):51-5. PubMed ID: 15735855
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers.
Yao M; Yu E; Staggs V; Fan F; Cheng N
Mod Pathol; 2016 Aug; 29(8):810-23. PubMed ID: 27125354
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic impact of peritumoral stromal remodeling in patients with surgically treated invasive penile squamous cell cancer.
Gunia S; Jain A; Albrecht K; Koch S; Otto W; Denzinger S; Götz S; Niessl N; Burger M; May M
Hum Pathol; 2014 Jun; 45(6):1169-76. PubMed ID: 24703102
[TBL] [Abstract][Full Text] [Related]
16. CD34(+) fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri.
Barth PJ; Ramaswamy A; Moll R
Virchows Arch; 2002 Dec; 441(6):564-8. PubMed ID: 12461613
[TBL] [Abstract][Full Text] [Related]
17. CD34(low) and SMA(high) represent stromal signature in uterine cervical cancer and are markers for peritumoral stromal remodeling.
Horn LC; Schreiter C; Canzler A; Leonhardt K; Einenkel J; Hentschel B
Ann Diagn Pathol; 2013 Dec; 17(6):531-5. PubMed ID: 24183311
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.
Nakagawa S; Miki Y; Miyashita M; Hata S; Takahashi Y; Rai Y; Sagara Y; Ohi Y; Hirakawa H; Tamaki K; Ishida T; Watanabe M; Suzuki T; Ohuchi N; Sasano H
Breast Cancer Res Treat; 2016 Jan; 155(1):65-75. PubMed ID: 26715212
[TBL] [Abstract][Full Text] [Related]
19. Correlation of p16 Expression on Cancer and Stromal Cells With Clinicopathologic and Immunohistochemical Features of Lobular Breast Carcinoma.
Harbhajanka A; Lamzabi I; Bitterman P; Reddy VB; Ghai R; Gattuso P
Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):658-662. PubMed ID: 31592814
[TBL] [Abstract][Full Text] [Related]
20. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions.
Chauhan H; Abraham A; Phillips JR; Pringle JH; Walker RA; Jones JL
J Clin Pathol; 2003 Apr; 56(4):271-6. PubMed ID: 12663638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]